Review Article

Graves Orbitopathy: Update on Diagnosis and Therapy

Graves orbitopathy (GO) is an autoimmune disorder representing the most frequent extrathyroidal manifestation of Graves disease. It is rare, with an age-adjusted incidence of approximately 16.0 cases per 100,000 population per year in women and 2.9 cases per 100,000 population per year in men. GO is an inflammatory process characterized…

Posted in: Graves disease 4 rituximab 4

Case Report

Nonpolypoid Intestinal Mantle Cell Lymphoma Resembling MALT Lymphoma with Successful Response to Rituximab

Two unusual cases of mantle cell lymphoma are reported. They involved the ileum and right colon without multiple lymphomatous polyposis and morphologically resembled an extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue (MALT) type.

Posted in: immunohistochemistry 3 mantle cell lymphoma 3 rituximab 4

Case Report

Rituximab Therapy for Refractory Thrombotic Thrombocytopenic Purpura and Autoimmune-Mediated Thrombocytopenia in Systemic Lupus Erythematosus

Abstract:Thrombotic thrombocytopenic purpura (TTP) rarely occurs in the setting of systemic lupus erythematosus (SLE); when it does occur it has a high mortality rate and is refractory to conventional treatment. No clear treatment guidelines exist when refractory TTP occurs in the setting of SLE. A 24-year-old male patient presented with…

Posted in: plasmapheresis 2 rituximab 4 systemic lupus erythematosus 9 thrombotic thrombocytopenic purpura 6

Case Report

Bilateral Perinephric Diffuse Large B-Cell Lymphoma and Synchronous Renal Oncocytoma

An elderly patient who presented with bilateral perinephric diffuse large B-cell lymphoma and concomitant oncocytoma of the same location is reported. To our knowledge, the anatomic proximity of the two tumors at the level of kidneys has not been previously described. Because of the patient’s other medical conditions, systemic chemotherapy…

Posted in: diffuse large B-cell lymphoma 4 rituximab 4
SMA Menu